Umhlaza waseTshayina wexabiso lezintso

Ukuqonda iindleko ezinxulumene nonyango lomhlaza wezintso eTshayina kunokuba nzima. Eli nqaku liqhekeza izinto ezahlukeneyo ezichaphazela ixabiso, kubandakanywa ukuxilongwa, ukhetho lonyango (utyando, i-chemotherapy, unyango olujoliswe kuyo, kunye ne-immunotherapy), ukhetho lwesibhedlele, kunye ne-inshurensi. Siphinde sihlolisise izibonelelo ezifumanekayo zokunceda ukulawula ezi ndleko, sinikezela ngenkcazo eneenkcukacha kwizigulane kunye neentsapho zabo zifuna ukucaciswa kwimiba yezemali yokunakekelwa komhlaza wezintso.Ukuqonda uMhlaza Wezintso eChina Umhlaza weKidney, owaziwa ngokuba yi-renal cell carcinoma (RCC), yinkxalabo ebalulekileyo yezempilo kwihlabathi jikelele, kwaye i-China ayinjalo. Ukufunyaniswa kwangoko kunye nonyango lubalulekile ekuphuculeni iziphumo zesigulana. Umhlaza waseTshayina wexabiso lezintso Iintlobo zoMhlaza WezintsoOlona hlobo luxhaphakileyo lomhlaza wezintso yirenal cell carcinoma (RCC), ebalelwa malunga nama-85% eemeko. Ezinye iintlobo ziquka i-transitional cell carcinoma kunye nethumba likaWilms, elifunyanwa ikakhulu ebantwaneni. Ukuqonda uhlobo oluthile lomhlaza kubalulekile ekumiseleni isicwangciso sonyango esifanelekileyo kunye neendleko. Nge IZiko loPhando ngoMhlaza laseShandong Baofa, sizinikele kuphando kunye nokubonelela ngeendlela zonyango zamva nje.Iizinto zoMngcipheko kunye noThinteloIzinto ezininzi ezinokunyusa umngcipheko wokuba nomhlaza wezintso, kuquka ukutshaya, ukutyeba, uxinzelelo lwegazi oluphezulu, kunye neemeko ezithile zofuzo. Amanyathelo okuthintela aquka ukugcina indlela yokuphila esempilweni, ukuphepha ukutshaya, nokulawula uxinzelelo lwegazi. Ukuhlolwa rhoqo, ngakumbi kubantu abanembali yosapho enomhlaza wezintso, kunokunceda ekubhaqweni kwangoko, okunokunciphisa umhlaza jikelele. Umhlaza waseTshayina wexabiso lezintso ngokuphepha unyango lwasemva kwexesha. Izinto eziphembelela iindleko zoNyango lomhlaza wezintso e-ChinaIxabiso lilonke lokunyanga umhlaza wezintso e-China linokwahluka kakhulu ngokuxhomekeke kwizinto ezininzi.Ukuxilongwa kunye ne-StagingInkqubo yokuqala yokuxilonga ibandakanya uluhlu lweemvavanyo zokuqinisekisa ubukho bomhlaza kunye nokumisela isigaba sawo. Iinkqubo zoxilongo eziqhelekileyo ziquka:Uvavanyo loMzimba: Uvavanyo oluqhelekileyo lwempilo yesigulane.Uvavanyo lomfanekiso: I-CT scans, i-MRIs, kunye ne-ultrasounds zisetyenziselwa ukujonga izintso kunye nezicubu ezijikelezileyo. Olu vavanyo lunceda ukufumanisa ubungakanani kunye nendawo yethumba.I-Biopsy: Isampuli yethishu encinci ithathwa kwizintso kwaye ihlolwe phantsi kwe-microscope ukuqinisekisa ubukho beeseli zomhlaza.Uvavanyo lwegazi kunye nomchamo: Ezi mvavanyo zinokunceda ukuvavanya ukusebenza kwezintso kunye nokuchonga iimpawu ezinokubakho ezinxulumene nomhlaza wezintso.Iindleko zezi nkqubo zinokwahluka phakathi kwezibhedlele. Ukuxilongwa kwangaphambili kunye ngokuchanekileyo kunokunciphisa ekugqibeleni Umhlaza waseTshayina wexabiso lezintso ngokuvumela ukhetho oluncinci lonyango.Ukhetho loNyango kunye noKhetho oluManyanisiweyo loNyango lomhlaza wezintso eTshayina lubandakanya utyando, ichemotherapy, unyango olujoliswe kuyo, kunye nonyango lomzimba. Ukukhethwa kwonyango kuxhomekeke kwinqanaba kunye nohlobo lomhlaza, kunye nempilo yonke yesigulane. Nalu ulwahlulo lwento nganye:Uqhaqho lolona nyango luphambili lomhlaza wezintso, ngakumbi ukuba umhlaza ungowalapha. Ukhetho lotyando lubandakanya:I-Radical Nephrectomy: Ukususwa kwezintso zonke, izicubu ezijikelezileyo, kwaye ngamanye amaxesha i-lymph nodes ekufutshane.I-Nephrectomy engaphelelanga: Ukususwa kwethumba ngelixa ugcina izicubu zezintso eziseleyo. Oku kudla ngokukhethwa kumathumba amancinci.I-Laparoscopic okanye uTyando lweRobhothi: Ubuchwephesha obuncinci obunokunciphisa ixesha lokubuyisela kunye ne-scarring.Indleko yokuhlinzwa ingahluka ngokuxhomekeka kuhlobo lwenkqubo kunye nesibhedlele. Utyando olungenelelayo oluncinci luhlala luneendleko eziphezulu ngaphambili kodwa lunokukhokelela ekuthotyweni jikelele Umhlaza waseTshayina wexabiso lezintso ngenxa yokuhlala ixesha elifutshane esibhedlele kunye nokuncipha kweengxaki. Unyango Ngamachiza Amachiza asetyenziswa kakhulu kumhlaza wezintso xa kuthelekiswa namanye ama-cancer, kodwa inokusetyenziswa kwiimeko ezithile, njengaxa umhlaza unwenwele kwamanye amalungu omzimba. Iindleko zechemotherapy zixhomekeke kumachiza athile asetyenziswayo kunye nobude bonyango. Ngenxa yokuba umhlaza wezintso usoloko uxhathisa kwichemotherapy yesintu, oku kaninzi ayingowonyango wokuqala.I-Targeted TherapyTargeted therapy therapy amayeza avimba iimolekyuli ezithile ezibandakanyekayo ekukhuleni kweeseli zomhlaza kunye nokusasazeka. Amachiza aqhelekileyo ekujoliswe kuwo kumhlaza wezintso abandakanya:I-Sunitinib (I-Sutent): Inqanda ii-receptors ezininzi ze-tyrosine kinase, ukunciphisa ukunikezelwa kwegazi kwi-tumor.I-Sorafenib (Nexavar): Indlela efanayo yokusebenza kwi-sunitinib.I-Pazopanib (I-Votrient): Enye inhibitor ye-tyrosine kinase.I-Axitinib (Inlyta): I-tyrosine kinase inhibitor ekhethiweyo ngakumbi.Iziyobisi zonyango ezijoliswe kuzo zingabiza, kwaye iindleko zinokwahluka ngokuxhomekeke kwiyeza kunye nobude bonyango. Iindleko zala mayeza zinokufaka isandla kakhulu kwinto yonke Umhlaza waseTshayina wexabiso lezintso. Ngokolwazi lomenzi, iindleko zenyanga ze-Sunitinib zinokuqala ukusuka kwi-￥20,000 ukuya kwi-￥40,000 e-China, kuxhomekeke kwidosi kunye ne-brand. (Umthombo: Pfizer China website esemthethweni).ImmunotherapyImmunotherapy amachiza anceda amajoni omzimba ukulwa umhlaza. Amachiza aqhelekileyo e-immunotherapy kumhlaza wezintso aquka:I-Nivolumab (Opdivo): I-PD-1 inhibitor ethintela iprotheni ekhusela iiseli zomzimba ekuhlaselweni kweeseli zomhlaza.I-Pembrolizumab (Keytruda): Enye inhibitor ye-PD-1.Ipilimumab (Yervoy): I-CTLA-4 inhibitor eyenza i-immune cell activity.Immunotherapy iziyobisi nazo ziyabiza, kwaye iindleko zinokwahluka ngokuxhomekeke kwiyeza kunye nobude bonyango. Ngelixa inokusebenza kakhulu, i-immunotherapy inokuba yinxalenye ebalulekileyo ye Umhlaza waseTshayina wexabiso lezintso. Iindleko zenyanga ze-Nivolumab zinokuba phezulu ngakumbi kunonyango olujoliswe kuyo, olunokufikelela kwi-￥50,000 okanye ngaphezulu. (Umthombo: Bristol Myers Squibb China website esemthethweni) .UkuKhethwa kweSibhedlele kunye neNdawoIindleko zonyango zinokuhluka kakhulu phakathi kwezibhedlele zaseChina. Izibhedlele zikawonke-wonke zibonelela ngeendleko eziphantsi kunezibhedlele zabucala okanye amaziko onyango ehlabathi. Nangona kunjalo, izibhedlele zabucala zinokubonelela ngamaxesha amafutshane okulinda kunye nokhathalelo lomntu. Indawo esikuyo isibhedlele sinokuchaphazela neendleko, izibhedlele ezikwizixeko ezikhulu zihlala zibiza kakhulu.Ukhuselo lwe-inshorensiUbungakanani bokhuseleko lwe-inshorensi bunokuba nefuthe elimandla kwiindleko eziphuma epokothweni kwizigulana. Abemi abaninzi baseTshayina bane-inshurensi yezempilo esisiseko ehlawula ezinye zeendleko zokuxilonga nonyango. Nangona kunjalo, i-coverage yonyango olutsha, olufana nonyango olujoliswe kuyo kunye ne-immunotherapy, inokulinganiselwa okanye ingabandakanywa konke konke. I-inshurensi eyongezelelweyo inokunceda ekuhlawuleni ezi ndleko zongezelelweyo. Ukuqonda ipolisi yakho ye-inshurensi kubalulekile ekulawuleni Umhlaza waseTshayina wexabiso lezintso.Ukuqikelela uMhlaza waseTshayina weNdleko yezintso: UkuqhekekaKungumceli mngeni ukunika uqikelelo oluchanekileyo lweendleko ezipheleleyo zonyango lomhlaza wezintso e-China ngenxa yokwahluka kwezinto ezikhankanywe ngasentla. Nangona kunjalo, nantsi ukucazululwa ngokubanzi kweendleko ezinokubakho: Uluhlu oluqikelelweyo lweendleko (RMB) Amanqaku oxilongo (Umfanekiso, iBiopsy) 5,000 - 20,000 Iyahluka ngokusekelwe kwinani kunye nohlobo lovavanyo. Utyando (Nephrectomy) 30,000 Kuxhomekeka kuhlobo lotyando (oluvulekileyo vs. kancinane invasive) kunye nesibhedlele. I-Chemotherapy (umjikelo ngamnye) 5,000 - 20,000 Ngaphantsi, kodwa ixabiso lixhomekeke kumachiza asetyenziswayo. Unyango olujolisiweyo (ngenyanga) 20,000 - 40,000+ Sunitinib, Sorafenib, Pazopanib, njl. Iindleko zixhomekeke kwiyeza elithile kunye nedosi. Immunotherapy (ngenyanga) 30,000 - 50,000+ Nivolumab, Pembrolizumab, njl. Ingabiza kakhulu. Ukuhlala esibhedlele (ngosuku) 500 - 2,000+ Iyahluka ngokusekelwe esibhedlele kunye nenqanaba lokunyamekela. Ukulandelela Unonophelo 2,000 - 10,000 (ngonyaka) Kubandakanya ukuhlolwa rhoqo kunye novavanyo lwemifanekiso. *Qaphela: Ezi ziindleko eziqikelelwayo kwaye zinokwahluka kakhulu.*Izixhobo zokulawula iiNdleko zoMhlaza wezintso eChinaUkujonga imiba yezemali yonyango lomhlaza wezintso kunokubanzima. Nazi ezinye izixhobo ezinokunceda:Iinkxaso zikaRhulumente: Eminye imimandla eTshayina ibonelela ngoncedo lonyango lomhlaza, ngakumbi kubantu abafumana umvuzo ophantsi. Jonga kurhulumente wakho wengingqi ukuze ubone ukuba uyafaneleka na.Imibutho yesisa: Imibutho efana neChina Cancer Foundation kunye namaqela enkxaso yomhlaza wengingqi anokunikezela ngoncedo lwemali okanye izixhobo zokunceda izigulana zilawule iindleko.Ukuxhaswa ngemali ngabantu abaninzi: Amaqonga afana ne-Shuidichou (水滴筹) avumela abantu ukuba banyuse imali yeendleko zonyango.IiNkqubo zoNcedo lwaMayeza: Ezinye iinkampani ezixuba amayeza zibonelela ngeenkqubo zoncedo lwesigulana ezinokunceda ukunciphisa iindleko zonyango ekujoliswe kulo kunye namachiza okuthomalalisa amajoni omzimba.Iinkonzo zokuHamba kwi-Inshurensi yezoNyango: Ezi nkonzo zinokukunceda uqonde ipolisi yakho ye-inshurensi kwaye ulandele inkqubo yamabango. Banokunceda kwakhona ukuchonga izixhobo ezinokubakho kunye neenkqubo zoncedo. Qhagamshelana IZiko loPhando ngoMhlaza laseShandong Baofa ngolwazi oluthe vetshe ngezibonelelo nenkxaso.IsipheloUkuqonda i Umhlaza waseTshayina wexabiso lezintso ibalulekile kwizigulana neentsapho zazo. Ngokuphanda iinketho zonyango, ukuphonononga ukhuseleko lwe-inshurensi, kunye nokusetyenziswa kwezibonelelo ezikhoyo, kunokwenzeka ukulawula umthwalo wemali wonyango lomhlaza wezintso kunye nokugxila ekubuyiseleni kwakhona. Ukufunyaniswa kwangaphambili, ukucwangciswa konyango olubanzi, kunye nokufikelela kwizibonelelo ezixhasayo zonke zibalulekile ekuphuculeni iziphumo zesigulane kunye nokunciphisa impembelelo yesi sifo.